282例β-内酰胺类抗菌药的不良反应分析

目的：了解我院2009—2010年β-内酰胺类抗菌药不良反应发生情况，分析其影响因素，以促进临床合理用药。方法：收集我院2009—2010年上报告国家药品不良反应监测中心的282例β-内酰胺类抗茵药的药品不良反应（ADR）报告，分别从患者年龄、性别、给药途径、使用药物种类以及临床表现等方面进行统计分析。结果：ADR涉及β-内酰胺类抗菌药共33种，以头孢曲松居首位，其次为头孢呋辛和氨曲南；以静脉途径给药引发的ADR最多；282例ADR中，大于60岁患者构成比最高（28．72％）；临床表现以皮肤及其附件损害最常见。结论：β-内酰胺类抗菌药发生ADR与年龄、给药途径等多种因素相关，应规范β-内酰胺类抗茵药的临床应用，减少ADR的发生。

Analysis for 282 Cases of Adverse Drug Reaction of β-lactam Antibiotics

Objective：To investigate the reality and affecting factors of adverse drug reaction（ADR ） induced by β-1actam antibiotics in our hospital during 2009-2010, in order to promote the rational use of drug in clinic. Method： We classified and analyzed 282 cases of ADR of β-lactam antibiotics which is reported to National center for ADR Monitoring during 2009 -2010, according to the aspects of patients＇age and gender, administration route, species of drugs and clinical manifestations. Result：The ADR were caused by a total of 33 species of β-lactam antibiotics agents, amongwhich Ceftriaxone ranked the first and was followed by Cefuroxime and Aztreonam; The most causing routewas intravenous administration; of which, those patients＇ aged above 60 years accounted for 28.72% ;the damage of skin and its annex were the most common clinical manifestations. Conclusion：Multiple factors contributed to the ADR, for example age and administration route. And the clinical application of β-lactam antibiotics of should be regulated to avoid or reduce the occurrence of ADR.